The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
The stroop smartphone APP is a short and valid method toscreen for minimal hepatic encephalopathy
Bajaj JS, Thacker LR, Heuman DM, Fuchs M, Sterling RK, Sanyal AJ, Puri P, Siddiqui MS, Stravitz RT, Bouneva I, Luketic V, Noble N, White MB, Monteith P, Unser A, Wade JB. Hepatology. 2013 Feb 6. doi: 10.1002/hep.26309. [Epub ahead of print]
Source
Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia. jsbajaj@vcu.edu.
Abstract
Minimal hepatic encephalopathy (MHE) detection is difficult due to the unavailability of short screening tools. Therefore MHE patients can remain undiagnosed and untreated. Aim: To use a Stroop smartphone application (EncephalApp_Stroop) to screen for MHE. Methods: The App and standard psychometric tests (SPT; 2/4 abnormal is MHE, gold standard), psychometric hepatic encephalopathy score(PHES) and Inhibitory control(ICT) tests were administered to cirrhotics [with/without prior-overt HE(OHE)] and age-matched controls from two centers; a subset underwent re-testing. A separate validation cohort was also recruited. Stroop has "off" state with neutral stimuli and "on" state with incongruent stimuli. Outcomes: time to complete five correct runs, number of trials needed in On(On time) and Off(Off time) states. Stroop results were compared between controls and cirrhotics with/without OHE, and those with/without MHE (using SPT,ICT,PHES). ROC analysis was performed to diagnose MHE in cirrhotics with/without prior OHE. Results: 125 cirrhotics (43 prior OHE) and 134 controls were included in the original cohort. App times were correlated with MELD (Off time :r=0.57,Ontime:r=0.61,p<0.0001) and were worst in prior-OHE patients compared to the rest and controls. Stroop performance was also significantly impaired in those with MHE compared to no-MHE according to SPT, ICT and PHES (all p<0.0001). A cut-off of>274.9seconds(OnTime+OffTime) had an AUC=0.89 in all patients and 0.84in patients without prior OHE for MHE diagnosis using SPT as the gold standard. The validation cohort showed 78% sensitivity and 90% specificity with the >274.9 secondsOnTime+OffTimecut-off. App result patterns were similar between the centers. Test-retest reliability in controls and those without prior OHE was good; a learning effect on Ontime in cirrhotics without prior OHE was seen. In conclusion, the Stroop smartphone app is a short, valid and reliable tool for screening of MHE.